A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic

International Journal of Dermatology

Volumn 36, Issue 9, 1997, Pages 667-672

  Goh, Chee Leok ^a   Khoo, Lawrence ^a  

^a NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT REFERRAL; POSTHERPETIC NEURALGIA; PREVALENCE; RETROSPECTIVE STUDY; SINGAPORE;

EID: 0030805299     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00241.x     Document Type: Article

References (26)

1. Rogers RS III, Tindall JP. Geriatric herpes zoster. JAm Geriatr Soc 1971; 19: 495-504.
2. Wood MJ, Ogan PH, McKendrick MW, et al. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988; 85: 79-83.
3. Gilden DH, Dueland AN, Cohrs R, et al. Preherpetic neuralgia. Neurology 1991; 41: 1215-1218.
4. Whitley RJ, Weiss H, Gnann J, et al. The efficacy of steroid and acyclovir therapy of herpes zoster in the elderly. JInvest Med 1995; 43(Suppl. 2): 2j2A (abstract).
5. McKendrick MW, McGill JI, White JE, Wood MJ. Oral acyclovir in acute herpes zoster. Br Med J 1986; 293:1519-153
6. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med J 1989; 102: 93-95-
7. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir.- Scaiid J Infect Dis Stippl 1991; So: 62-68.
8. DeGreef H. Famciclovir. A new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrobials Agents 1994; 4: 41-46.
9. Beutner KR, Friedman DJ, Forszaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-1553.
10. Hope-Simpson RE. Postherpetic neuralgia. JR Coll Gen Pract 1975; 25: 571-575.
11. Ragozzino MW, Melton LJ III, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1981; 61: 310-316.
12. Burgoon CF Jr, Burgeoon JS, Baldrige GD. The natural history of herpes zoster. JAm Med Assoc 1957; 164: 165-169.
13. Gynn C, Crockford G, Gavaghan D, et al. Epidemiology of shingles. JR Soc Med 1990; 83: 617-619.
14. de Moragas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol 1957; 75: 193-197.
15. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-10.
16. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Epidemiology of herpes zoster in children and adolescents: a population based study. Pediatrics 1985; 76: 5I2-5I7
17. Rusthoven JJ, Ahlgren P, Elhakim T, et al. Varicellazoster infection in adult cancer patients: a population study. Arch Intern Med 1988; 148: 1561-1566.
18. Hardy I, Gershon AA, Steinberg SP, La Russa P. Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunisation with live attenuated varicella vaccine: study in children with leukemia. N Engl J Med 1991;325= 1545-1550.
19. Freidman-Kein AE, Lafleur FL, Gendler E, et al. Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk . . individuals. J Am Acad Dermatol 1986; 14: 1013-1018.
20. Gilden DH, Dueland AN, Devlin ME, et al. Varicella' zoster virus reactivation without rash. JInfect Dis 1991; i66(Suppl. i): 530-534.
21. Kost RG3 Straus SE. Postherpetic neuralgiapathogenesis, treatment and prevention. N Engl J Med 1996; 335= 32-4
22. Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neitropharmacol 1984; 7: 51-81.
23. Swerdlow M. The treatment of "shooting" pain. Postgrad Med] 1980; 56: 159-161.
24. Watson CPN, Watt VR, Chipman M, et al. The prognosis with postherpetic neuralgia. Pain 1991; 46: 195-199.
25. Epstein E. Treatment of zoster and postzoster neuralgia by the intralesional injection of triamcinolone: a computer analysis of 199 cases. Int ] Dermatol 1976; 15: 761-769.
26. Balfour HH Jr. Varicella zoster virus infections in immunocompromised hosts: a review of the natural history and management. Am J Med 1988; 85: 68-73.